Inventor · disambiguated record
Susan Irene Hershenson
Also filed as: HERSHENSON SUSAN · HERSHENSON SUSAN I · HERSHENSON SUSAN IRENE
17 granted patents·13 pending applications·551 citations·filing 1986–2021
95Inventor score
Top patents by PatentIndex Score
30 records- 0196US6733753B2Composition and method for treating inflammatory diseasesAMGEN INC·Filed 2001·Granted May 11, 2004·73 cites·16 claims
- 0294US6294170B1Composition and method for treating inflammatory diseasesAMGEN INC·Filed 1998·Granted Sep 25, 2001·122 cites·15 claims
- 0392US6020469AStem cell factor formulations and methodsAMGEN INC·Filed 1999·Granted Feb 1, 2000·86 cites·5 claims
- 0490US6500429B2Antibodies against analogs of brain-derived neurotrophic factorAMGEN INC·Filed 2000·Granted Dec 31, 2002·19 cites·3 claims
- 0586US6723701B2Protein analogs of brain-derived neurotrophic factorAMGEN INC·Filed 2000·Granted Apr 20, 2004·11 cites·7 claims
- 0684US5183746AFormulation processes for pharmaceutical compositions of recombinant β-SCHERING AG·Filed 1987·Granted Feb 2, 1993·85 cites·7 claims
- 0782US5004605ALow pH pharmaceutical compositions of recombinant β-interferonCETUS CORP·Filed 1987·Granted Apr 2, 1991·72 cites·16 claims
- 0882US4894330APurification of recombinant beta-interferon incorporating RP-HPLCCETUS CORP·Filed 1986·Granted Jan 16, 1990·48 cites·34 claims
- 0979US11607451B2Self-buffering antibody formulationsAMGEN INC·Filed 2013·Granted Mar 21, 2023·1 cites·96 claims
- 1079US11136563B2Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapyUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Oct 5, 2021·1 cites·6 claims
- 1178US9822347B2Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapyUNIV LELAND STANFORD JUNIOR·Filed 2013·Granted Nov 21, 2017·3 cites·3 claims
- 1269US2022220458A1Modified AXL Peptides and Their Use in Inhibition of AXL Signaling in Anti-Metastatic TherapyUNIV LELAND STANFORD JUNIOR·Filed 2021·Application pending·0 cites
- 1363US4961969AProcess for recovering microbially produced interferon-βCETUS CORP·Filed 1987·Granted Oct 9, 1990·18 cites·21 claims
- 1463US2017368170A1Self-buffering protein formulationsAMGEN INC·Filed 2017·Application pending·0 cites
- 1562US2005143294A1Analogs of cationic proteinsAMGEN INC·Filed 2003·Application pending·0 cites
- 1660US2016367666A1Self-buffering protein formulationsAMGEN INC·Filed 2016·Application pending·0 cites
- 1759US2016367665A1Self-buffering protein formulationsAMGEN INC·Filed 2016·Application pending·0 cites
- 1859US2016319011A1Self-buffering protein formulationsAMGEN INC·Filed 2016·Application pending·0 cites
- 1959US2016362486A1Self-buffering protein formulationsAMGEN INC·Filed 2016·Application pending·0 cites
- 2059US2016339102A1Self-buffering protein formulationsAMGEN INC·Filed 2016·Application pending·0 cites
- 2159US2016362484A1Self-buffering protein formulationsAMGEN INC·Filed 2016·Application pending·0 cites
- 2259US2016362485A1Self-buffering protein formulationsAMGEN INC·Filed 2016·Application pending·0 cites
- 2356US2002013258A1Novel stem cell factor formulations and methodsAMGEN INC·Filed 2000·Application pending·0 cites
- 2456US2008311078A1Self-Buffering Protein FormulationsGOKARN YATIN R·Filed 2006·Application pending·0 cites
- 2555US6468970B2Analogs of NT-3AMGEN INC·Filed 2001·Granted Oct 22, 2002·0 cites·8 claims
- 2655US2012028877A1Self-Buffering Protein FormulationsGOKARN YATIN R·Filed 2011·Application pending·0 cites
- 2750US6288030B1Stem cell factor formulations and methodsAMGEN INC·Filed 1993·Granted Sep 11, 2001·9 cites·13 claims
- 2838US5965522AStem cell factor formulations and methodsAMGEN INC·Filed 1998·Granted Oct 12, 1999·2 cites·2 claims
- 2934US6211150B1Analogs of cationic proteinsAMGEN INC·Filed 1997·Granted Apr 3, 2001·1 cites·13 claims
- 3032US6271364B1Analogs of NT-3AMGEN INC·Filed 1999·Granted Aug 7, 2001·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →